MedTrace Logo

Efficacy and Safety of the Liquid Embolic System (Tonbridge) for Endovascular Treatment of Cerebrovascular Malformations

NCT06479343 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 170

Last updated 2024-09-19

No results posted yet for this study

Summary

The purpose of this study is to verify the efficacy and safety of the Liquid Embolic System (Tonbridge Medical Tech. Co., Ltd. (Suzhou)) for the treatment of cerebrovascular malformations.

Conditions

  • Intracranial Arteriovenous Malformations

Interventions

DEVICE

Liquid Embolic System (Tonbridge)

Endovascular treatment with Liquid Embolic System (Tonbridge).

DEVICE

Onyx Liquid Embolic System (Medtronic)

Endovascular treatment with Onyx Liquid Embolic System (Medtronic).

Sponsors & Collaborators

  • Ton-Bridge Medical Tech. Co., Ltd

    lead INDUSTRY

Principal Investigators

  • Peng Zhang · Xuanwu Hospital, Beijing

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-06-27
Primary Completion
2025-10-31
Completion
2026-10-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06479343 on ClinicalTrials.gov